Metabolistics Inc. Founded with the vision of providing clear and concise reports on a woman's risk of developing these diseases, Metabolistics quickly became the foremost metabolomic testing company in the world. Their innovative approach allowed patients to collect a sample in just 5 minutes, and after processing, they would receive a detailed report on their current risk of developing breast or ovarian cancer.

These reports could be accessed through their doctor or on the company's website. Metabolistics recognized that their business model was risky, as they relied on direct payment from clients, while many were accustomed to social healthcare. However, they believed that economies of scale would eventually address this challenge.

Unfortunately, this did not turn out as expected, leading to the regretful decision to shut down the company. Metabolistics would like to express their sincere gratitude to their users for their trust and support during what was often a difficult time. They would also like to extend their appreciation to the dedicated employees who contributed to the company's mission.

Even though Metabolistics is no longer in operation, their pioneering work in metabolomic testing has made a lasting impact on the field of cancer screening